Renaissance Technologies’s Shockwave Medical SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-52,100
Closed -$17M – 4081
2024
Q1
$17M Sell
52,100
-94,400
-64% -$23.2M 0.03% 712
2023
Q4
$27.9M Sell
146,500
-110,100
-43% -$20.8M 0.04% 484
2023
Q3
$51.1M Buy
256,600
+53,800
+27% +$12.7M 0.09% 255
2023
Q2
$57.9M Buy
202,800
+6,600
+3% +$1.83M 0.08% 276
2023
Q1
$42.5M Sell
196,200
-206,400
-51% -$40.2M 0.06% 395
2022
Q4
$82.8M Buy
402,600
+79,900
+25% +$20.2M 0.11% 199
2022
Q3
$89.7M Buy
322,700
+279,500
+647% +$71.1M 0.13% 181
2022
Q2
$8.26M Buy
43,200
+33,800
+360% +$5.97M 0.01% 1213
2022
Q1
$1.95M Sell
9,400
-43,100
-82% -$7.11M ﹤0.01% 2249
2021
Q4
$9.36M Sell
52,500
-10,700
-17% -$2.11M 0.01% 1110
2021
Q3
$13M Sell
63,200
-38,500
-38% -$7.56M 0.02% 882
2021
Q2
$19.3M Buy
+101,700
New +$16.6M 0.02% 780
2020
Q2
– Sell
-25,200
Closed -$836K – 3837
2020
Q1
$836K Buy
+25,200
New +$1M ﹤0.01% 2511
2019
Q4
– Sell
-151,790
Closed -$4.54M – 3800
2019
Q3
$4.54M Buy
151,790
+44,190
+41% +$1.88M ﹤0.01% 1845
2019
Q2
$6.14M Buy
+107,600
New +$5.23M 0.01% 1699

Other funds holding SWAV

Renaissance Technologies's SWAV Position: Q2 2024 in Review

Renaissance Technologies sold out of Shockwave Medical (SWAV) in Q2 2024, closing a stake of 52,100 shares — an estimated $17M sold.

Renaissance Technologies first reported a position in SWAV in Q2 2019 and held it in 15 quarters. The position peaked at $89.7M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Renaissance Technologies reported no remaining Shockwave Medical position as of Q2 2024 after selling out during the quarter.
  • Renaissance Technologies sold 52,100 Shockwave Medical shares in Q2 2024, an estimated $17M.
  • Renaissance Technologies first reported a position in Shockwave Medical in Q2 2019 and held it in 15 quarters.
  • Renaissance Technologies's Shockwave Medical position peaked at $89.7M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical as of Q2 2024.

Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.